Nuclear Medicine from a Novel Perspective: Buvat and Weber Talk with OpenAI's ChatGPT

Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers.

The Lancet. Haematology·2026

Clinical PET/MR.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026

Prognostic Value of [18F]Flotufolastat PET Using Visual RECIP in Docetaxel-Treated Metastatic Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Brain Metabolic Activity Measured by [18F]FDG PET/CT Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

CMV seropositivity associates with poor clinical outcome in triple negative breast cancer.

iScience·2026

Prognostic value of TMTV and Dmax calculated from 18F-fluorodeoxyglucose positron emission tomography images in metastatic cutaneous melanoma treated with immune checkpoint blockade.

European journal of nuclear medicine and molecular imaging·2026

Are Urooncologists Onboard?

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Radiopharmaceutical Therapy-Linked Tumor Resistance: Immune Evasion, Nonimmune Mechanisms, and Immunometabolic Vulnerabilities.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Pivotal Phase 3 Theranostic Trials: Future Indications.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

The Case for Nuclear Oncology Specialization: Training Physicians for Radiopharmaceutical Therapy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Telitacicept for primary angiitis of the central nervous system: A real-world retrospective study.

Therapeutic advances in neurological disorders·2026

Nanotheranostics in orthopedic diseases: a critical review of molecular diagnostic-driven targeted therapeutics for personalized patient care.

Expert review of molecular diagnostics·2026

Limonin ameliorates hyperuricemia-induced cognitive impairment through modulation of microglial HIF-1α-driven neuroinflammation.

International immunopharmacology·2026

Beyond the skin barrier: nanocarrier-based drug delivery with emerging insights into the gut-skin axis and probiotic modulation in atopic dermatitis.

The Journal of pharmacy and pharmacology·2026

A 3D in vitro co-culture model to investigate tumor-endothelial interactions in Neurofibromatosis type 2-associated meningiomas.

Neuro-oncology advances·2026

Molecular mechanisms and translational potential of plant-derived nanovesicles in skin care and regeneration.

Frontiers in cell and developmental biology·2026

Related Experiment Videos

Nuclear Medicine from a Novel Perspective: Buvat and Weber Talk with OpenAI's ChatGPT

Related Concept Videos

Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers.

Clinical PET/MR.

Prognostic Value of [18F]Flotufolastat PET Using Visual RECIP in Docetaxel-Treated Metastatic Prostate Cancer.

Brain Metabolic Activity Measured by [18F]FDG PET/CT Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer.

CMV seropositivity associates with poor clinical outcome in triple negative breast cancer.

Prognostic value of TMTV and Dmax calculated from 18F-fluorodeoxyglucose positron emission tomography images in metastatic cutaneous melanoma treated with immune checkpoint blockade.

Are Urooncologists Onboard?

Radiopharmaceutical Therapy-Linked Tumor Resistance: Immune Evasion, Nonimmune Mechanisms, and Immunometabolic Vulnerabilities.

Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.

Pivotal Phase 3 Theranostic Trials: Future Indications.

Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer.

The Case for Nuclear Oncology Specialization: Training Physicians for Radiopharmaceutical Therapy.

Telitacicept for primary angiitis of the central nervous system: A real-world retrospective study.

Nanotheranostics in orthopedic diseases: a critical review of molecular diagnostic-driven targeted therapeutics for personalized patient care.

Limonin ameliorates hyperuricemia-induced cognitive impairment through modulation of microglial HIF-1α-driven neuroinflammation.

Beyond the skin barrier: nanocarrier-based drug delivery with emerging insights into the gut-skin axis and probiotic modulation in atopic dermatitis.

A 3D in vitro co-culture model to investigate tumor-endothelial interactions in Neurofibromatosis type 2-associated meningiomas.

Molecular mechanisms and translational potential of plant-derived nanovesicles in skin care and regeneration.

Related Experiment Videos

Nuclear Medicine from a Novel Perspective: Buvat and Weber Talk with OpenAI's ChatGPT

Related Concept Videos

Related Articles